How can ECP be positioned in the current GvHD treatment landscape as a steroid-free intervention?
The GvHD Hub spoke with Robert Zeiser, University of Freiburg, Freiburg, DE. We asked, How can ECP be positioned in the current GvHD treatment landscape as a steroid-free intervention?
During this interview, Zeiser discusses the potential positioning of extracorporeal photopheresis (ECP) in the treatment landscape for acute graft-versus-host disease (GvHD) and chronic GvHD, noting that corticosteroids remain the standard first-line treatment in both settings. He highlights the steroid-sparing potential of ECP and considers its role as a second- or later-line treatment option, either alone…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.